Is Initial Dasatinib-Blinatumomab Therapy for Ph-Positive ALL in Adults Cost Effective?

被引：0
|
作者：
Bitran, Jacob D. [1 ]
Nabrinsky, Edward [2 ]
Bufalino, Shams [3 ]
Knouse, Phillip [2 ]
Galvez, Angel G. [2 ]
机构：
[1] Advocate Lutheran Gen Hosp, Bone Marrow Transplantat Program, Hematol & Oncol IM, Park Ridge, IL USA
[2] Advocate Lutheran Gen Hosp, Park Ridge, IL USA
[3] Advocate Lutheran Gen Hosp, Bone Marrow Transplantat Program, Park Ridge, IL USA
来源：
BLOOD | 2021年 / 138卷
关键词：
D O I：
10.1182/blood-2021-144656
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4962
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Dasatinib-Blinatumomab for Ph-Positive ALL
    Foa, Robin
    Chiaretti, Sabina
    NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (04): : 384 - 384
  • [2] Dasatinib-Blinatumomab for Ph-Positive Acute Lymphoblastic Leukemia in Adults
    Foa, Robin
    Bassan, Renato
    Vitale, Antonella
    Elia, Loredana
    Piciocchi, Alfonso
    Puzzolo, Maria-Cristina
    Canichella, Martina
    Viero, Piera
    Ferrara, Felicetto
    Lunghi, Monia
    Fabbiano, Francesco
    Bonifacio, Massimiliano
    Fracchiolla, Nicola
    Di Bartolomeo, Paolo
    Mancino, Alessandra
    De Propris, Maria-Stefania
    Vignetti, Marco
    Guarini, Anna
    Rambaldi, Alessandro
    Chiaretti, Sabina
    NEW ENGLAND JOURNAL OF MEDICINE, 2020, 383 (17): : 1613 - 1623
  • [3] BLINATUMOMAB WITH DASATINIB AND INTRATHECAL THERAPY FOR RELAPSED PH-POSITIVE ALL WITH CNS RELAPSE
    Zembillas, Anthony
    Bielek, Kathy
    Mathanda, Reema
    Stanton, Michael
    Rotz, Seth
    PEDIATRIC BLOOD & CANCER, 2021, 68 : S141 - S142
  • [4] Dasatinib and dexamethasone followed by hematopoietic cell transplantation for adults with Ph-positive ALL
    Wieduwilt, Matthew J.
    Yin, Jun
    Wetzler, Meir
    Uy, Geoffrey L.
    Powell, Bayard L.
    Kolitz, Jonathan E.
    Liedtke, Michaela
    Stock, Wendy
    Beumer, Jan H.
    Mattison, Ryan J.
    Storrick, Elizabeth
    Christner, Susan M.
    Lewis, Lionel D.
    Devine, Steven
    Stone, Richard M.
    Larson, Richard A.
    BLOOD ADVANCES, 2021, 5 (22) : 4691 - 4700
  • [5] Long-Term Results of the Dasatinib-Blinatumomab Protocol for Adult Philadelphia-Positive ALL
    Foa, Robin
    Bassan, Renato
    Elia, Loredana
    Piciocchi, Alfonso
    Soddu, Stefano
    Messina, Monica
    Ferrara, Felicetto
    Lunghi, Monia
    Mule, Antonino
    Bonifacio, Massimiliano
    Fracchiolla, Nicola
    Salutari, Prassede
    Fazi, Paola
    Guarini, Anna
    Rambaldi, Alessandro
    Chiaretti, Sabina
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (08) : 881 - 885
  • [6] Dasatinib is an effective treatment of central nervous system Ph-positive leukemia
    Koskenvesa, P.
    Rimpilainen, J.
    Lundan, T.
    Mustjoki, S.
    Brethon, B.
    Hjorth-Hansen, H.
    Hoglund, M.
    Knutsen, H.
    Parikh, S.
    Raffoux, E.
    Stromsheim, J.
    Agren, L.
    Gruber, F.
    Strauss, L.
    Talvensaari, K.
    Dombret, H.
    Elonen, E.
    Paquette, R.
    Simonsson, B.
    Zwaan, C. M.
    Porkka, K.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 113 - 114
  • [7] Dasatinib and CAR-T Cell Therapy for Newly Diagnosed Ph-Positive Acute Lymphoblastic Leukemia in Adults
    Zhang, Mingming
    Hu, Yongxian
    Wei, Guoqing
    Fu, Shan
    Feng, Jingjing
    Hong, Ruimin
    Chang, Alex H.
    Huang, He
    BLOOD, 2023, 142
  • [8] DASATINIB ALONE CAN ALLOW MRD NEGATIVE COLLECTION IN PATIENTS WITH PH-POSITIVE ALL: A CASE REPORT
    Cimminiello, M.
    Pizzuti, M.
    Vertone, D.
    Attolico, I.
    Poggiaspalla, M.
    Magaldi, A.
    Grippo, T.
    Musto, C.
    Olivieri, A.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 : 465 - 466
  • [9] Ponatinib: hope for patients with CML or Ph-positive ALL?
    Yaqub, Farhat
    LANCET ONCOLOGY, 2013, 14 (13): : E588 - E588
  • [10] Phase 2 trial of induction with dasatinib and consolidation with hyper-CVAD plus dasatinib followed by allografting for Ph-positive acute lymphoblastic leukemia in adults
    Oh, Iekuni
    Hatano, Kaoru
    Ikeda, Takashi
    Toda, Yumiko
    Minakata, Daisuke
    Kawaguchi, Shinichiro
    Morita, Kaoru
    Yamamoto, Chihiro
    Ashizawa, Masahiro
    Sato, Kazuya
    Kameda, Kazuaki
    Gomyo, Ayumi
    Misaki, Yukiko
    Kawamura, Shunto
    Kimura, Shunichi
    Kobayashi, Hiroyuki
    Sato, Hiroyuki
    Nakasone, Hideki
    Ohmine, Ken
    Fujiwara, Shinichiro
    Kako, Shinichi
    Kanda, Yoshinobu
    LEUKEMIA RESEARCH, 2024, 137
12345